← Back
$XERS All transactions

Xeris Biopharma Holdings, Inc.

▼ SELL 10b5-1 Plan

$ Value

$120K

Shares

15,000

Price

$8

Filed

Jan 9

Insider

Name

McCulloch Kevin

Title

See Remarks

CIK

0002031695

Roles

Officer

Transaction Details

Transaction Date

2026-01-08

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,685,426

Footnotes

The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. | The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Filing Info

Accession No.

0002031695-26-000002

Form Type

4

Issuer CIK

0001867096

McCulloch Kevin's History

Date Ticker Type Value
2026-01-31 XERS F $504K
2026-01-31 XERS F $223K
2026-01-31 XERS F $201K
2026-01-30 XERS A $0
2026-01-30 XERS A $0
2026-01-08 XERS $120K
2025-10-02 XERS F $6K
2025-09-11 XERS J $0
2025-08-01 XERS F $79K
2025-06-13 XERS $109K

Other Insiders at XERS (90d)

Insider Bought Sold Last
Shannon John Patrick Jr
See Remarks
2026-01-31
Hecht Beth
See Remarks
$224K 2026-04-01
Pieper Steven
See Remarks
2026-01-31
Brady James Aloysius $60K 2026-03-30
McCulloch Kevin
See Remarks
2026-01-31
Nguyen Anh Tu
See Remarks
2026-01-30